TRVI· Trevi Therapeutics Inc.
Insider buys/sells · last 6 mo · open market only
| Transactions | Total $ | |
|---|---|---|
| Buys | 0 | $0 |
| Sells | 0 | $0 |
Quarterly ownership history
Last 5 quarters
TRVI Financials
Live via yfinance — refreshed daily.
Valuation
Market capitalization$2.1B
Enterprise value$1.9B
EV / EBITDA (TTM)-35.87
P/E ratio (TTM)—
Forward P/E-27.62
P/S ratio—
P/B ratio10.15
PEG ratio—
Cash Flow
Operating cash flow (TTM)-$45M
Free cash flow (TTM)-$29M
Total cash$172M
Total debt$682K
Debt / equity0.40
Current ratio24.75
Income Statement
Total revenue (TTM)—
Revenue per share (TTM)—
Gross profit (TTM)—
EBITDA (TTM)-$53M
Net income (TTM)-$46M
EPS diluted (TTM)-0.32
Shares outstanding141,979,708
Float shares117,506,666
Profitability
Gross margin0.00%
Operating margin0.00%
EBITDA margin0.00%
Net margin0.00%
Efficiency
Return on assets (TTM)-23.02%
Return on equity (TTM)-33.59%
Price History
Current price$14.50
52 Week high$16.12
52 Week low$5.38
50 day average$12.85
200 day average$10.87
Average volume (10 day)1,725,960
1-year beta1.08
1-year price target$22.36
Dividends
Dividend yield—
Dividend rate (annual)—
Payout ratio0.00%
Fundamentals are sourced from yfinance and refreshed daily. Last updated May 10, 2026, 5:42 PM. Empty cells (—) mean yfinance doesn't have that field for this ticker (common for ADRs, recent IPOs, or non-applicable ratios).
Real-time alerts. We'll let you know when a whale you follow files a new 13F, or a stock you follow has insider activity. No weekly digest.
whalstreet
★ WatchlistData from SEC EDGAR · whalstreet.com